(1/10) Very grateful to see our paper published in @PsychMedJournal. Let me take you on a brief tour of this family study in individuals with #22q11DS: 2/10 While we are able to describe risk of neuropsychiatric outcomes at the group level, for individuals with pathogenic variants, our ability regarding individualized outcome prediction lags behind, as does our ability to identify mechanisms and additional factors of impact.